#91: Marco Schmidt - AI in Drug Discovery and Drug Development: What You Need to Know
Podcast |
Beginner's Mind
Publisher |
Christian Soschner
Media Type |
audio
Categories Via RSS |
Business
Entrepreneurship
Investing
Technology
Publication Date |
Nov 21, 2022
Episode Duration |
02:11:48

What is the Role of Artificial Intelligence in Drug Development and Drug Discovery?⭐ In this episode, we talk about:

  • Deep Mind’s Alphafold
  • Investing in Life Science companies
  • The State of AI in Drug Development and Drug Discovery
  • How does GDPR limit the development of AI in Drug Discovery
  • The Human Genome and AI

Today’s speaker is Marco Schmidt, CSO of Biotx.aiMarco had an exceptional academic career. He won the best PhD of the year award in Chemistry in his home country Germany and then went on to do a Post-Doc at the University of Cambridge.⭐ EPISODE Links:Marco Schmidt on Linkedin Youtube 📖 Quotes:(24:45) “Eroom's law is the observation that drug discovery is becoming slower and more expensive over time”(56:05) “We need more data”(58:13) “Biobanks provide the infrastructure that we really need in the future”(01:16:39) “Prediction Models of Type 2 Diabetes Have 99% Accuracy”(01:17:50) “There is no longevity gene. There are shortevity genes.”(01:53:45) “We are living in fantastic times” ⏰ Timestamps:(00:00) Kick Off and Intro(06:15) Deep Mind’s Alphafold(07:06) Background to Marco Schmidt and Biotx.ai (12:00) Business Model in AI for Drug Development – from Service Provider to Developer(13:15) Basic Definition of Drug Discovery and Drug Development for the Listeners of the Episode(17:20) For Retail Investors who have an eye on investing in public drug development companies: What is a Ligand?(20:09) Why is Drug Discovery Expensive and Lengthy?(23:30) Success and Failure Rate in Drug Development(24:30) What is erooms Law?(27:25) What is the right place for innovation? Startups or Big Corporations?(30:00) The Value Chain in the Pharma Industry – From Research to Marketed Products.(34:00) Investing in Life Science Companies(50:15) Why is Artificial Intelligence an Attractive Area?Speaker and Company(55:00) The State of AI in Drug Development and Drug Discovery – What is Science and What is Still Fiction.(58:00) Accessibility of Data – Is this the bottleneck in Artificial Intelligence Based Drug Discovery?(01:10:00) What would change in Drug Development if scientists could access healthy population data?(01:12:30) Prediction Models for Cancer, Alzheimer, and other

How to Start a Podcast Guide: The Complete GuideLearn how to plan, record, and launch your podcast with this illustrated guide. Make More with Matt HeslinExplore strategies to thrive financially, build legacy, and enhance life experiences.

Listen on: Apple Podcasts   Spotify

Coaching Conversations in 2024

In 2024 we're going to be going to monthly themes and I would also encourage you to...

Listen on: Apple Podcasts   Spotify

The LSG2G PartnersExperts in Life ScienceDisclaimer: This post contains affiliate links. If you make a purchase, I may receive a commission at no extra cost to you.

Support the Show.

Join the Podcast Newsletter: Link

This episode currently has no reviews.

Submit Review
This episode could use a review!

This episode could use a review! Have anything to say about it? Share your thoughts using the button below.

Submit Review